RECRUITING

Reading Outcomes in Children With Vestibular Loss

Talk to us

Conditions

Vestibular DisorderHearing Loss, Sensorineural

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Vestibular loss can co-occur with hearing loss causing dual sensory deficits. This project examines vestibular loss as a contributing factor to reading difficulties for children with hearing loss, where previously only the effects of hearing loss and subsequent language difficulties have been considered. These results are expected to influence the identification and habilitation of vestibular loss in children with hearing loss.

Official Title

Reading Outcomes in Children With Vestibular Loss

Quick Facts

Study Start:2022-06-06
Study Completion:2026-06-30
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05414903

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:8 Years to 14 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:CHILD
Inclusion CriteriaExclusion Criteria
  1. * Children will be required to have nonverbal problem-solving/intelligence scores within 1.5 SD of the mean (mean = 100, SD = 15, 1.5 SD of mean = 77 - 123).
  2. * Children with normal hearing must have thresholds ≤20 dB HL from 0.25 to 8 kHz.
  3. * Children with hearing loss must have pure-tone averages \> 65 dB HL.
  1. * Fail a vision screen at 20/30
  2. * Have autism, blindness, or other optic disorders, cerebral palsy, significant neurologic involvement, uncorrectable vision problems, and intellectual disability.
  3. * Children with nonverbal problem-solving/intelligence scores \> 123 or \< 77 will be excluded.
  4. * Each participant's current medications will be reviewed. Children taking medications known to result in oculomotor slowing will be excluded (i.e., anti-depressants, vestibular suppressants, sedatives, etc).

Contacts and Locations

Study Contact

Kristen L Janky, PhD
CONTACT
15313556535
kristen.janky@boystown.org
Jessie N Patterson, PhD
CONTACT
15313556333
jessie.patterson@boystown.org

Principal Investigator

Kristen L Janky, PhD
PRINCIPAL_INVESTIGATOR
Father Flanagan's Boys' Home

Study Locations (Sites)

Boys Town National Research Hospital
Omaha, Nebraska, 68131
United States

Collaborators and Investigators

Sponsor: Father Flanagan's Boys' Home

  • Kristen L Janky, PhD, PRINCIPAL_INVESTIGATOR, Father Flanagan's Boys' Home

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2022-06-06
Study Completion Date2026-06-30

Study Record Updates

Study Start Date2022-06-06
Study Completion Date2026-06-30

Terms related to this study

Additional Relevant MeSH Terms

  • Vestibular Disorder
  • Hearing Loss, Sensorineural